Official UK procurement notice
NP49024 Growth Hormone · UK public procurement notice
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)
What is being bought2 lots · detail below
Published requirement descriptionThis Framework Agreement is for the supply of Growth Hormone to health boards across NHS Scotland.
CPV: Pharmaceutical products
How this framework works
From the published notice- Places
- up to 5 suppliers · 4 bids on the busiest of 2 lots (0.8 per place) · 4 appointed
Lots and requirements (2)Procurement structure
2 lots · all with a published value · same evaluation weights on every lotLot #1Growth Hormone Daily DoseAwardedRenewalPublished value£15,550,000
Supply of Growth Hormone (daily dose) to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework.
Lot #2Growth Hormone Long-ActingAwardedRenewalPublished value£450,000
Supply of Growth Hormone (Long Acting) to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per product line.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (6)
- Storage Conditions: 4%
- Homecare: 4%
- Ancillaries: 4%
- Indications: 4%
- Waste Reduction: 4%
- price: 80%
Published award criteria (6)
- Storage Conditions: 4
- Homecare: 4
- Ancillaries: 4
- Indications: 4
- Waste Reduction: 4
- Price: 80
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualificat…
- Price carries 80 of 100 points: a 10% discount moves about 8 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP49024 Growth Hormone” is a framework: the contest is a place on its panel, up to 5 suppliers, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 13 Sept 2024, 12:29 BST
- Last source update
- 13 Jan 2025, 10:39 GMT
- Award evaluation window
- 14 Oct 2024 – …
- FTS notice number
2025/S 000-000987- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-049ab4Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.1.5 [and within all Lots] cover(s) the thirty six month contract duration and the 12 month extension period of the framework agreement. (SC Ref:784209)
How it was run
Official notice- Appointment period ends
- 14 Oct 2024, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 14 Oct 2024, 12:00 BST
Timeline
14 Oct 2024 → 13 Jan 2025 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown14 Oct 2024, 12:00 BST
- Bids opened14 Oct 2024, 12:00 BST
- Notice published13 Jan 2025, 10:39 GMT
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete13 Jan 2025, 10:39 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast2 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Growth Hormone Daily Dose
- Signed
- 7 Jan 2025
- Value
- £15,300,000
- Status
- active
Growth Hormone Long-Acting
- Signed
- 7 Jan 2025
- Value
- £451,000
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · Growth Hormone Daily Dose | 4bids · 4 electronic · 4 from abroad | 0 | — | — |
| 2 · Growth Hormone Long-Acting | 2bids · 2 electronic | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
4 commercial parties on the notice- Merck Serono LimitedFramework contractor
- Novo Nordisk LtdFramework contractor
- Pfizer LtdFramework contractor
- SandozFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.